OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, revenue was VND 872,974.33 million compared to VND 771,349.04 million a year ago. Net income was VND 106,555.25 million compared to VND 89,563.52 million a year ago. Basic earnings per share from continuing operations was VND 1,664 compared to VND 1,247 a year ago. Diluted earnings per share from continuing operations was VND 1,664 compared to VND 1,247 a year ago.